Quantcast

Latest Heart failure Stories

2014-07-31 08:37:20

Doctors at Virginia Commonwealth University Medical Center discuss the benefits and use of the SynCardia Total Artificial Heart in a PubMed-indexed case report and video that includes implant surgery of 60-year-old man. TUCSON, Ariz., July 31, 2014 /PRNewswire/ -- For the first time, cardiac surgeons, medical professionals and the public can watch the implantation of the SynCardia temporary Total Artificial Heart in a peer reviewed case report paper and matching video posted on the...

2014-07-28 08:29:32

-- Next-generation HNO prodrug targeting severe heart failure was well tolerated and showed hemodynamic activity in a Phase I clinical trial -- CHAPEL HILL, N.C., July 28, 2014 /PRNewswire/ -- Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers. The company has now initiated dosing of hospitalized...

2014-07-23 23:26:50

EECP Treatment is FDA-Cleared for Refractory Angina and Offered at Dr. Weaver’s EECP Independent Outpatient Facility in the U.S. Los Angeles, CA (PRWEB) July 22, 2014 Ronald S. Weaver, MD, owner of Global Cardio Care Centers in Inglewood, Calif., today announced a heart transplant patient with cardiomyopathy has successfully completed a course of Enhanced External Counterpulsation (EECP) therapy at Global Cardio Care Centers and is no longer a candidate for heart transplant. The...

2014-07-23 12:30:34

CLEVELAND, July 23, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, a clinical-stage biotechnology company developing a first-in-class regenerative gene therapy for treatment of heart failure announced adding two industry veterans to its leadership team. Dale Sander has joined as Chief Financial Officer. Dr. Francis Plat will serve in an advisory capacity as Chief Strategy Officer. http://photos.prnewswire.com/prnvar/20131028/DC04442LOGO Mr. Sander has more than 20 years of...

2014-07-23 08:27:25

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cardiac Biomarkers: Technologies and Global Marketshttps://www.reportbuyer.com/product/2070047/Cardiac-Biomarkers-Technologies-and-Global-Markets.html REPORT HIGHLIGHTSThe global market for in vitro diagnostic tests for cardiac biomarkers was estimated at $3.1 billion in 2012 and nearly $4 billion in 2013. This market is predicted to reach $7.2 billion by 2018, at a compound annual growth...

2014-07-22 12:29:46

Ronald Fontana is discharged home while he waits for a matching donor heart transplant. He is enjoying his family, thanks to the SynCardia Total Artificial Heart powered by the Freedom Portable Driver. TUCSON, Ariz., July 22, 2014 /PRNewswire/ -- A central New York recipient of a SynCardia temporary Total Artificial Heart implant is home, discharged from University of Rochester's Strong Memorial Hospital with the Freedom® portable driver to wait for a matching donor heart....

2014-07-16 12:27:35

Now the Freedom® portable driver is available to all clinically stable SynCardia Total Artificial Heart patients in the US so they can be discharged from the hospital to enjoy life with family while waiting for their donor hearts. TUCSON, Ariz., July 16, 2014 /PRNewswire/ -- The Freedom® portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically...

2014-07-15 10:29:05

BMJ-British Medical Journal Inability to register surprise strongest indicator; can help prioritize care, say doctors Patients with serious heart and lung conditions don't have the normal range of facial expressions, particularly the ability to register surprise in response to emotional cues, finds preliminary research published online in Emergency Medicine Journal. This finding could be used to help busy emergency care doctors decide whom to prioritize for treatment, and gauge who...

2014-07-15 08:29:29

HARRISBURG, Pa., July 15, 2014 /PRNewswire/ -- Following a heart attack, many heart failure patients suffer from enlargement of their left ventricle, diminishing the amount of blood the heart can pump to the body and resulting in life-threatening left-sided heart failure symptoms such as shortness of breath, decreased urine production, fatigue, and irregular or rapid heartbeat. Treatment options for patients whose left ventricle has enlarged have been limited, until now. Through a...

2014-06-27 23:07:08

Dr. Arash Bereliani, cardiologist at the Institute for Cardiology and Preventive Medicine in Beverly Hills, comments on a recent study linking processed red meat and heart failure. Los Angeles, CA (PRWEB) June 27, 2014 A new study in Circulation: Heart Failure, a medical journal put out by the American Heart Association, has found a link between a higher risk of heart failure and the consumption of processed red meat in men. The study was conducted by researchers at the Karolinska...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »
Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related